Results
76,350 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Flammer Martina M.D.Chief Medical Officer |  INSMINSMED IncOption exercise · 10b5-1 plan | M | — 18.3K sh | Aug 7, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Flammer Martina M.D.Chief Medical Officer | INSMINSMED Inc Option exercise · 10b5-1 plan | M | — 18.3K sh | Aug 7, 2026 |
| 4 | Werner Ryan D.SVP, CAO |  RIOTRiot Platforms, Inc.Open-market sale · 10b5-1 plan | SELL | $224K 9,802 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 4 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner |  PUBMPubMatic, Inc.Derivative conversion · 10b5-1 plan | C | — 211.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 3 | Walsh Mark T.Director, CEO & Director |  SVVSavers Value Village, Inc.Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 3 | Ditillo DavidChief Information Officer |  CRBGCorebridge Financial, Inc.Option exercise · 10b5-1 plan | M | — 3,914 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 3 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 2 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpGrant or award | A | — 15.00M sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER |  ACADACADIA PHARMACEUTICALS INCOption exercise · 10b5-1 plan | M | $104K 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 2 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 2 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Grant or award | A | — 15.00M sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Coyne Terrance P.EVP & CFO |  RPRXRoyalty Pharma plcGrant or award | A | — 11.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 2 | Urist MarshallEVP, Research & Investments | RPRXRoyalty Pharma plc Grant or award | A | — 8,252 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks |  YOUClear Secure, Inc.Option exercise · 10b5-1 plan | M | — 323.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $11K 7,941 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Xu ZhenyuChief Scientific Officer |  SOPHSOPHiA GENETICS SAOption exercise · 10b5-1 plan | M | $9,840 3,000 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $7,050 5,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 14.3K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $11K 7,941 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $158K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Atay OguzhanDirector, Chairman and CEO |  BLLNBillionToOne, Inc.Option exercise · 10b5-1 plan | M | $44K 15.5K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Mayes Patrick AEVP & Chief Scientific Officer |  INCYINCYTE CORPOption exercise · 10b5-1 plan | M | $235K 2,207 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Mayes Patrick AEVP & Chief Scientific Officer | INCYINCYTE CORP Option exercise · 10b5-1 plan | M | — 2,207 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Ditillo DavidChief Information Officer | CRBGCorebridge Financial, Inc. Option exercise · 10b5-1 plan | M | $79K 3,914 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $7,050 5,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | PUBMPubMatic, Inc. Option exercise · 10b5-1 plan | M | — 211.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Atay OguzhanDirector, Chairman and CEO | BLLNBillionToOne, Inc. Option exercise · 10b5-1 plan | M | $44K 15.5K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $23K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Disposition to issuer · 10b5-1 plan | D | — 323.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Walsh Mark T.Director, CEO & Director | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Xu ZhenyuChief Scientific Officer | SOPHSOPHiA GENETICS SA Option exercise · 10b5-1 plan | M | $23K 7,000 sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Flammer Martina M.D.Chief Medical Officer | INSMINSMED Inc Option exercise · 10b5-1 plan | M | — 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Geisser Melinda L.Chief People Services Officer | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $71K 50.0K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Flammer Martina M.D.Chief Medical Officer | INSMINSMED Inc Option exercise · 10b5-1 plan | M | $230K 8,895 sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER | ACADACADIA PHARMACEUTICALS INC Option exercise · 10b5-1 plan | M | — 5,849 sh | Aug 7, 2026 traded Aug 5, 2026 |
| 0 | Alclear Investments, LLCDirector, 10% Owner, See Remarks | YOUClear Secure, Inc. Grant or award · 10b5-1 plan | A | — 323.9K sh | Aug 7, 2026 traded Aug 6, 2026 |
| 0 | Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner | PUBMPubMatic, Inc. Derivative conversion · 10b5-1 plan | C | — 211.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 0 | Medway Richard A.General Counsel | SVVSavers Value Village, Inc. Option exercise · 10b5-1 plan | M | $33K 23.3K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 35 |  David J. TaylorRSelf |  MSFTMICROSOFT CORPPurchase | BUY | $1,001 – $15K | Aug 6, 2026 traded Jul 24, 2026 |
| 35 | David J. TaylorRSelf |  GOOGLAlphabet Inc.Purchase | BUY | $1,001 – $15K | Aug 6, 2026 traded Jul 17, 2026 |